170 related articles for article (PubMed ID: 21613457)
1. Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.
Kuo J; Nardelli DT; Warner TF; Callister SM; Schell RF
Clin Vaccine Immunol; 2011 Jul; 18(7):1125-32. PubMed ID: 21613457
[TBL] [Abstract][Full Text] [Related]
2. Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice.
Nardelli DT; Luedtke JO; Munson EL; Warner TF; Callister SM; Schell RF
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):78-89. PubMed ID: 20662925
[TBL] [Abstract][Full Text] [Related]
3. Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice.
Amlong CA; Nardelli DT; Peterson SH; Warner TF; Callister SM; Schell RF
Clin Vaccine Immunol; 2006 Feb; 13(2):289-96. PubMed ID: 16467340
[TBL] [Abstract][Full Text] [Related]
4. Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.
Peterson SH; Nardelli DT; Warner TF; Callister SM; Torrealba JR; Schell RF
Clin Vaccine Immunol; 2007 May; 14(5):510-7. PubMed ID: 17360856
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.
Nardelli DT; Warner TF; Callister SM; Schell RF
Clin Vaccine Immunol; 2006 Aug; 13(8):884-91. PubMed ID: 16893988
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi.
Burchill MA; Nardelli DT; England DM; DeCoster DJ; Christopherson JA; Callister SM; Schell RF
Infect Immun; 2003 Jun; 71(6):3437-42. PubMed ID: 12761128
[TBL] [Abstract][Full Text] [Related]
7. Role of IL-17, transforming growth factor-beta, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice.
Nardelli DT; Kevin Luk KH; Kotloski NJ; Warner TF; Torrealba JR; Callister SM; Schell RF
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):265-74. PubMed ID: 18522647
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species.
Kotloski NJ; Nardelli DT; Peterson SH; Torrealba JR; Warner TF; Callister SM; Schell RF
Clin Vaccine Immunol; 2008 Aug; 15(8):1199-207. PubMed ID: 18579699
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.
Hansen ES; Medić V; Kuo J; Warner TF; Schell RF; Nardelli DT
Infect Immun; 2013 Dec; 81(12):4421-30. PubMed ID: 24042116
[TBL] [Abstract][Full Text] [Related]
10. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.
Nardelli DT; Burchill MA; England DM; Torrealba J; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1075-84. PubMed ID: 15539509
[TBL] [Abstract][Full Text] [Related]
11. Arthritis is developed in Borrelia-primed and -infected mice deficient of interleukin-17.
Kuo J; Warner TF; Munson EL; Nardelli DT; Schell RF
Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27493062
[TBL] [Abstract][Full Text] [Related]
12. Arthritis is inhibited in Borrelia-primed and infected interleukin-17A-deficient mice after administration of anti-gamma-interferon, anti-tumor necrosis factor alpha and anti-interleukin-6 antibodies.
Kuo J; Warner TF; Schell RF
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859307
[TBL] [Abstract][Full Text] [Related]
13. Borrelia-primed and -infected mice deficient of interleukin-17 develop arthritis after neutralization of gamma-interferon.
Kuo J; Warner TF; Schell RF
Pathog Dis; 2017 Mar; 75(2):. PubMed ID: 28175297
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection.
Nardelli DT; Cloute JP; Luk KH; Torrealba J; Warner TF; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2005 Jun; 12(6):786-92. PubMed ID: 15939755
[TBL] [Abstract][Full Text] [Related]
15. CD4+ cell-derived interleukin-17 in a model of dysregulated, Borrelia-induced arthritis.
Hansen ES; Johnson ME; Schell RF; Nardelli DT
Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27549424
[TBL] [Abstract][Full Text] [Related]
16. Tick-Tattoo: DNA Vaccination Against
Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
Front Immunol; 2021; 12():615011. PubMed ID: 33717102
[TBL] [Abstract][Full Text] [Related]
17. Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.
Munson EL; Du Chateau BK; Jobe DA; Lovrich SD; Callister SM; Schell RF
Infect Immun; 2000 Oct; 68(10):5496-501. PubMed ID: 10992445
[TBL] [Abstract][Full Text] [Related]
18. Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha.
Christopherson JA; Munson EL; England DM; Croke CL; Remington MC; Molitor ML; DeCoster DJ; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2003 Jan; 10(1):44-52. PubMed ID: 12522038
[TBL] [Abstract][Full Text] [Related]
19. Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.
Siitonen R; Pietikäinen A; Liljenbäck H; Käkelä M; Söderström M; Jalkanen S; Hytönen J; Roivainen A
Arthritis Res Ther; 2017 Nov; 19(1):254. PubMed ID: 29166944
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
Grosenbaugh DA; Rissi DR; Krimer PM
Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
